Insider · CIK 0001301120

Moreadith Randall

Reports to the SEC for 3 companies · HUNTSVILLE, AL

sec.gov

Transactions

Companies

Filings

CIK

0001301120

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+85.6K sh	—	—	85,558
2026-03-23	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,500 sh	—	—	267,686
2026-03-23	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,500 sh	$0.06	+$390	6,500
2026-03-23	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,500 sh	$2.86	−$18.6K	0
2026-03-19	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−39K sh	—	—	274,186
2026-03-19	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+39K sh	$0.06	+$2,340	39,000
2026-03-19	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−39K sh	$2.50	−$97.5K	0
2026-02-03	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+69K sh	—	—	69,000
2026-02-02	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,500 sh	$3.03	−$19.7K	0
2026-02-02	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,500 sh	—	—	313,186
2026-02-02	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,500 sh	$0.06	+$390	6,500
2026-01-28	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,500 sh	$3.57	−$23.2K	0
2026-01-28	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,500 sh	$0.06	+$390	6,500
2026-01-28	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,500 sh	—	—	319,686
2026-01-22	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,500 sh	—	—	326,186
2026-01-22	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,500 sh	$2.95	−$7,375	0
2026-01-22	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,500 sh	$0.06	+$150	2,500
2026-01-21	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,000 sh	$3.00	−$6,000	0
2026-01-21	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,000 sh	—	—	328,686
2026-01-21	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,000 sh	$0.06	+$120	2,000
2026-01-20	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,000 sh	$0.06	+$120	2,000
2026-01-20	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,000 sh	$3.07	−$6,140	0
2026-01-20	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,000 sh	—	—	330,686
2026-01-14	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,084 sh	$2.50	−$2,713.36	0
2026-01-14	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,084 sh	$0.06	+$65.04	1,084
2026-01-14	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,084 sh	—	—	332,686
2026-01-13	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,416 sh	$2.50	−$13.5K	0
2026-01-13	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,416 sh	—	—	333,770
2026-01-13	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,416 sh	$0.06	+$324.96	5,416
2026-01-08	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−13K sh	$2.69	−$35K	0
2026-01-08	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−13K sh	—	—	339,186
2026-01-08	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+13K sh	$0.06	+$780	13,000
2025-12-23	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,100 sh	—	—	352,186
2025-12-23	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,100 sh	$2.60	−$10.7K	0
2025-12-23	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,100 sh	$0.06	+$246	4,100
2025-12-22	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,673 sh	—	—	356,286
2025-12-22	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,673 sh	$2.67	−$15.2K	0
2025-12-22	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,673 sh	$0.06	+$340.38	5,673
2025-12-16	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,227 sh	$0.06	+$193.62	3,227
2025-12-16	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,227 sh	—	—	361,959
2025-12-16	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,227 sh	$2.96	−$9,561.924	0
2025-12-12	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,700 sh	$3.26	−$5,541.49	0
2025-12-12	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,700 sh	—	—	365,186
2025-12-12	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,700 sh	$0.06	+$102	1,700
2025-12-11	SERSerina Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,555 sh	$0.06	+$213.3	3,555
2025-12-11	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,555 sh	$3.24	−$11.5K	0
2025-12-11	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,555 sh	—	—	366,886
2025-12-10	SERSerina Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−645 sh	—	—	370,441
2025-12-10	SERSerina Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+645 sh	$0.06	+$38.7	645
2025-12-10	SERSerina Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−645 sh	$3.35	−$2,160.75	0

Recent filings

Accepted (ET)
May 264
Moreadith Randall0001301120-26-000021
SEC(opens sec.gov)
Mar 244
Moreadith Randall0001301120-26-000018
SEC(opens sec.gov)
Mar 204
Moreadith Randall0001301120-26-000016
SEC(opens sec.gov)
Feb 174
Moreadith Randall0001301120-26-000014
SEC(opens sec.gov)
Feb 34
Moreadith Randall0001301120-26-000012
SEC(opens sec.gov)
Jan 294
Moreadith Randall0001301120-26-000010
SEC(opens sec.gov)
Jan 234
Moreadith Randall0001301120-26-000008
SEC(opens sec.gov)
Jan 214
Moreadith Randall0001301120-26-000006
SEC(opens sec.gov)

Companies

Address

601 GENOME WAY, SUITE 2001

HUNTSVILLE, AL, 35806